We’re thrilled to participate in the annual DxPx conference in Düsseldorf on November 15th and 16th, 2022 as well as being one of the Bronze Sponsors of the event.
A rapidly changing market, interdisciplinarity, and technological breakthroughs, such as CRISPR, mean companies must rapidly adapt to ensure their success or risk being left behind. Molecular diagnostics has revolutionized the healthcare decision-making process opening up unlimited opportunities for companies in molecular testing, next-generation sequencing, and development of medical devices. Tapping into our experience ensures your success.
